Table 1.
Testicular cancer patient characteristics and clinicopathologic features for the full cohort and among different racial groups
| Total (n = 56,898) | NHW (n = 42,556) | HW (n = 9282) | Black (n = 1602) | API (n = 2607) | P-value | |
|---|---|---|---|---|---|---|
| Marital status | < 0.001 | |||||
| Single | 23,707(42.2) | 16,341(38.4) | 5121(55.2) | 877(54.7) | 1298(49.8) | |
| Married | 26,663(47.5) | 21,624(50.8) | 3383(36.5) | 516(32.2) | 1080(41.4) | |
| Separated/D/W | 3518(6.3) | 2850(6.7) | 425(4.6) | 118(7.4) | 118(4.5) | |
| Age group | < 0.001 | |||||
| 0–39 | 38,408(68.4) | 27,663(65.0) | 7731(83.3) | 1051(65.6) | 1846(70.8) | |
| 40–64 | 15,309(27.2) | 12,293(30.1) | 1374(14.8) | 483(30.1) | 609(23.4) | |
| 65+ | 2475(4.4) | 1766(4.8) | 177(1.9) | 68(4.2) | 152(5.8) | |
| Age at diagnosis | 35.9 ± 17.2 | 37.0 ± 15.1 | 30.7 ± 15.3 | 36.2 ± 14.2 | 35.1 ± 14.8 | < 0.001 |
| Survival time | 109.0 | 124.0 | 67.0 | 84.5 | 85.0 | < 0.001 |
| (months) | (41.0,191.0) | (51.0,214.0) | (21.0,135.0) | (27.5161.0) | (29.0,174.0) | |
| Subtype | < 0.001 | |||||
| Seminomas | 29,423(52.4) | 23,018(54.1) | 4165(44.9) | 835(52.1) | 1321(50.7) | |
| Teratoma | 13,947(24.8) | 9945(23.4) | 3013(32.5) | 320(20.0) | 635(24.4) | |
| ECs | 6447(11.5) | 5079(11.9) | 977(10.5) | 121(7.6) | 256(9.8) | |
| Non-seminomas | 1521(2.7) | 1010(2.4) | 366(3.9) | 60(3.8) | 81(3.1) | |
| Others | 4854(8.6) | 3504(8.) | 761(8.2) | 266(16.6) | 314(12.0) | |
| Location | < 0.001 | |||||
| Undescended testis | 969(1.7) | 611(1.4) | 208(2.2) | 61(3.8) | 88(3.4) | |
| Descended testis | 19,451(34.6) | 13,699(32.2) | 4378(47.2) | 448(28.0) | 891(34.2) | |
| Testis (NOS) | 35,772(63.7) | 28,246(66.4) | 4696(50.6) | 1093(68.2) | 1628(62.5) | |
| Stage | < 0.001 | |||||
| In situ | 97(0.2) | 63(0.2) | 22(0.2) | 9(0.5) | 3(0.1) | |
| Localized | 36,513(65.0) | 28,136(66.2) | 5718(61.6) | 919(57.4) | 1638(62.8) | |
| Regional | 10,173(18.1) | 7671(18.0) | 1751(18.9) | 315(19.7) | 415(15.9) | |
| Distant | 6472(11.5) | 4388(10.3) | 1486(16.0) | 244(15.3) | 340(13.0) | |
| Tumor size (mm) | 45.7 ± 36.3 | 42.3 ± 33.2 | 52.4 ± 41.2 | 57.4 ± 44.0 | 53.0 ± 42.5 | < 0.001 |
| Regional nodes | < 0.001 | |||||
| All nodes negative | 7693(14.4) | 5948(14.6) | 1124(13.1) | 253(16.8) | 360(14.8) | |
| ≥1 nodes positive | 45,676(85.6) | 34,797(85.4) | 7436(86.9) | 1253(83.2) | 2072(85.2) | |
| Treatment | < 0.001 | |||||
| Surgery | 22,848(40.2) | 16,710(39.3) | 3914(42.2) | 638(39.8) | 1021(39.2) | |
| CS | 15,542(27.3) | 11,152(26.2) | 3073(33.1) | 452(28.2) | 741(28.4) | |
| RS | 15,176(26.7) | 12,382(29.1) | 1693(18.2) | 352(22.0) | 637(24.4) | |
| CRS | 1336(2.4) | 970(2.3) | 214(2.3) | 54(3.4) | 94(3.6) | |
| Chemotherapy | 964(1.7) | 615(1.5) | 236(2.5) | 53(3.3) | 56(2.2) | |
| No treatment | 790(1.4) | 552(1.3) | 114(1.2) | 42(2.6) | 44(1.7) | |
| Radiation | 119(0.2) | 97(0.2) | 11(0.1) | 3(0.2) | 4(0.2) | |
| CR | 123(0.2) | 78(0.2) | 27(0.3) | 8(0.5) | 10(0.4) |
Cancers diagnosed between 1973 and 2015 in the SEER 9 database. Data are median (interquartile range) for survival time, mean ± standard deviation for age at diagnosis and tumor size, and count (percentage) for all categorical variables.
NHW non-Hispanic whites, HW Hispanic whites, API Asians and Pacific Islanders, ECs embryonal carcinomas, CS chemotherapy plus surgery, RS radiotherapy plus surgery, CRS chemotherapy plus radiotherapy plus surgery, CR chemotherapy plus radiotherapy